Organization
New York University and Manhattan Veterans Affairs
1 abstract
Abstract
Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.Org: Yale Cancer Center, Yale School of Medicine, New Haven, CT, Yale School of Medicine, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University,